An In Vitro Model to Evaluate Muscle Damage Following Intramuscular Injections
- 1 January 1989
- journal article
- research article
- Published by Springer Nature in Pharmaceutical Research
- Vol. 06 (2) , 167-170
- https://doi.org/10.1023/a:1015940811827
Abstract
An isolated rat muscle preparation was developed to screen for muscle damage (myotoxic potential) following intramuscular injections. Myotoxicity is evaluated by the total cumulative efflux of the enzyme creatine kinase from the extensor digitorum longus muscle into the incubation medium over a 2-hr period or by the slope of the cumulative creatine kinase efflux curve. The system allows for rapid screening of compounds and/or formulations regarding their myotoxic potential and is not sensitive to fluctuations of in vivo creatine kinase levels caused by animal handling or patient conditions. A good rank-order correlation was obtained between this in vitro technique and the in vivo myotoxicity of a number of pharmaceutical formulations, as indicated by circulating creatine kinase levels and histological observations.This publication has 29 references indexed in Scilit:
- Tests for Local Toxicity of Intramuscular Drug Preparations: Comparison of in Vivo and in Vitro MethodsActa Pharmacologica et Toxicologica, 2009
- An in vitro model for assessing muscle irritation due to parenteral antibioticsFundamental and Applied Toxicology, 1987
- The rate of elimination and distribution volume of rabbit muscle creatine phosphokinase.CHEMICAL & PHARMACEUTICAL BULLETIN, 1983
- Creatine KinaseCRC Critical Reviews in Clinical Laboratory Sciences, 1982
- Physico-Chemical Properties and Local Toxic Effects of InjectablesThe Tohoku Journal of Experimental Medicine, 1979
- A Comparative Study of Serum Creatine Phosphokinase (CPK) Activity in Rabbits, Pigs and Humans after Intramuscular Injection of Local Damaging Drugs*Acta Pharmacologica et Toxicologica, 1978
- Polyethylene Glycol as a Solvent for Diazepam: Bioavailability and Clinical Effects after Intramuscular Administration, Comparison of Oral, Intramuscular and Rectal Administration, and Precipitation from Intravenous SolutionsActa Pharmacologica et Toxicologica, 1976
- The Effect on Serum Enzymes of Intramuscular Injections of Digoxin, Bumetanide, Pentazocine and Isotonic Sodium ChlorideActa Medica Scandinavica, 1976
- The parenteral toxicity of clindamycin 2-phosphate in laboratory animalsToxicology and Applied Pharmacology, 1974
- Effect of Intramuscular Injections on Serum Creatine Phosphokinase ActivityThe Lancet Healthy Longevity, 1970